Knowledge · Published 22 Nov 2026
Who pays for access management: the hospital or the supplier?
A system for the access of external professionals costs money. Who pays seems a detail, but it decides whether suppliers take part, how quickly a hospital can start and who feels ownership. In the US the representative usually pays. This article sets both models side by side, fairly.
The American model: the representative pays
In the US, representatives usually pay for their own credentialing. GHX Vendormate uses tiers of 305, 360 and 415 dollars a year. A comparison of providers cites amounts between 295 and 550 dollars. According to a petition, the price at symplr went from 385 to 600 dollars a year.
For hospitals that is attractive: the system costs them little, and costs grow with the number of visitors. The supplier has an interest too, since without valid registration its specialist does not get in. The cost lies with the party that wants access.
The downside is resistance. The petition against the price increases shows that representatives feel cornered: they have to pay to do their job, with no say over the price.
The other model: the hospital pays
In the other model, the hospital pays and the professional is free. The argument: responsibility for who is in the theatre lies with the hospital. Dutch law on quality of care, professional registration and the treatment agreement places it there, and the Dutch Medical Technology Guideline asks the hospital for a procedure for external staff. Whoever has the duty pays for the means.
This model removes a barrier for suppliers. They do not have to buy anything to take part, and a professional has no reason not to register. That matters, because a shared profile does not work without suppliers.
The downside: the hospital needs a budget, has to make a purchasing decision and bears the cost even when many externals come. A hospital that does not feel the problem will not pay.
What the choice means in the Netherlands
No figures were found on the number of product specialists and engineers in the Netherlands. Every calculation is therefore an estimate. If suppliers pay, with an estimated 3,000 to 8,000 externals at 100 to 250 euros per person per year, the market at full coverage comes to 0.3 to 2 million euros; that number of externals is not substantiated. If hospitals pay 10,000 to 30,000 euros a year, across all 69 hospital organisations that comes to 0.7 to 2.1 million euros. That is an estimate too.
More important than size is acceptance. A model in which suppliers pay without the backing of their trade associations, such as Nefemed or FHI, risks the same resistance as in the US. A model in which hospitals pay needs a hospital that wants to own the issue.
Siimsa's proposal, and why
Siimsa proposes that the hospital pays and the professional is always free. The proposal is indicative and still being tested in interviews: 75 euros per operating theatre per month, with other restricted departments at no extra charge, and a minimum of 400 euros per month. Set-up costs a one-off 4,500 euros. A three-month pilot costs 3,000 euros and is credited if you continue.
By way of illustration: under this proposal a hospital with ten theatres would pay 750 euros a month, and a clinic with three theatres the minimum of 400 euros.
The reasons for this choice are that responsibility lies with the hospital, and the resistance to the American model. Whether hospitals are willing to pay is not yet proven.
Related topics
Sources
- zoek.officielebekendmakingen.nl/ah-tk-20192020-2093.pdf
- richtlijnendatabase.nl/richtlijn/leidraad_medische_technologie_in_instellingen_voor_medisch-specialistische_zorg
- gogreensecurity.com/market-comparision-and-buyer-guide
- change.org/p/stop-unjustified-price-increases-in-medical-device-credentialing
- ghx.com/resources/product-information/ghx-vendormate-access-tiers
Written with the help of AI based on our market research, with sources; not legal advice.